RecruitingNot ApplicableNCT07517887

Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure

Anti-aging Efficacy Study on One Cosmetic Product vs Untreated


Sponsor

Amazentis SA

Enrollment

30 participants

Start Date

Apr 22, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to investigate the impact of a topical product on skin health and aging


Eligibility

Min Age: 45 YearsMax Age: 65 Years

Inclusion Criteria8

  • Written Informed Consent to participate in the study
  • Written Informed Consent for the use of the images for marketing purposes applies to subgroup participants of study 26.0112.
  • Willingness to actively participate in the study and to come to the scheduled visits
  • Female
  • Male, approximately 10 to 15% with little facial hair
  • From 45 to 65 years of age
  • Healthy skin in the test areas
  • Visible wrinkles in the face (grade 3 to 6 according to proderm wrinkle score)

Exclusion Criteria19

  • Female participants: Pregnancy or lactation
  • Drug addicts, alcoholics
  • AIDS, HIV-positive or infectious hepatitis
  • Conditions which exclude a participation or might influence the test reaction/evaluation
  • Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
  • Active skin disease at the test area
  • Documented allergies to face/eye care products or their ingredients
  • Diabetes mellitus
  • Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
  • One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases
  • Epilepsy
  • Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation
  • Regular use of tanning beds within the last 6 weeks prior to the start of the study
  • Any topical medication at the test area within the last 3 days prior to the start of the study
  • Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) within the last 7 days prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study
  • Therapy with antibiotics within the last 2 weeks prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study
  • Cosmetic surgery procedure in the test area (e.g. laser, facelift) within the last 2 years and throughout the entire course of the study
  • Cosmetic surgery treatments in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study and throughout the entire course of the study
  • Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study and throughout the entire course of the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSkin care product

The cosmetic skin care product will be applied twice daily to half of the face


Locations(1)

SGS proderm GmbH

Schenefeld, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07517887


Related Trials